BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
Open | $2.840 |
Close | $2.820 |
Volume / Avg. | 335.951K / 1.560M |
Day Range | 2.790 - 2.905 |
52 Wk Range | 1.910 - 29.560 |
Market Cap | $86.226M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 35.54% |
Days to Cover | 3.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Anixa Biosciences (NASDAQ:ANIX), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM) and Connect Biopharma Hldgs (NASDAQ:CNTB).
The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by HC Wainwright & Co. on Monday, March 18, 2024. The analyst firm set a price target for 11.00 expecting BTAI to rise to within 12 months (a possible 290.07% upside). 26 analyst firms have reported ratings in the last year.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $2.82 last updated March 28, 2024 at 4:57 PM EDT.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.